Detalles de la búsqueda
1.
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Ann Hematol
; 94(1): 23-34, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25096636
2.
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.
Haematologica
; 95(10): 1754-61, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20494931
Resultados
1 -
2
de 2
1
Próxima >
>>